Status: Recruiting
Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)
This is a phase II double-blind, placebo-controlled study of artesunate ointment for the treatment of HPV-associated vulvar HSIL (usual type vulvar intraepithelial neoplasia 2/3).
Participants needed: 27
Trial details
Phase: Phase 2Age: 18+Biological sex: FemaleType: InterventionalSponsor: Frantz Viral Therapeutics, LLCUpdated: Aug 14, 2025Locations: 5
Eligibility criteria
Adult women age ≥ 18 years [+10]
Pregnant and nursing women [+10]